Healthcare Third-Party Logistics Market Report 2026

The healthcare third-party logistics market size has grown strongly in recent years. It will grow from $258.69 billion in 2025 to $283.07 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to expansion of pharmaceutical distribution networks, increasing biologics and vaccine transportation, rising outsourcing of healthcare logistics, growth of global clinical trials, increasing regulatory scrutiny on drug distribution.

The healthcare third-party logistics market size is expected to see strong growth in the next few years. It will grow to $401.07 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing investments in smart healthcare logistics platforms, rising demand for cryogenic and ultra-cold storage, expansion of ai-enabled logistics optimization, growing adoption of sustainable transport solutions, increasing focus on resilient healthcare supply chains. Major trends in the forecast period include increasing adoption of cold chain monitoring technologies, rising demand for end-to-end supply chain visibility, growing integration of real-time tracking solutions, expansion of automated healthcare warehousing, enhanced focus on regulatory-compliant logistics.

The growing demand for vaccines is expected to drive the expansion of the healthcare third-party logistics market going forward. Vaccines are biological formulations that activate the body’s immune system to identify and combat specific diseases by simulating an infection without causing illness. The rising demand for vaccines is primarily attributed to the increasing prevalence of infectious diseases, as more individuals seek protection against widespread health risks. Healthcare third-party logistics supports vaccine distribution by ensuring safe, timely, and temperature-controlled transportation and storage across the supply chain. For instance, in July 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that global coverage of the first dose of the HPV vaccine among girls rose from 20% in 2022 to 27% in 2023, with a target of achieving 90% coverage by 2030. Therefore, the growing demand for vaccines is driving the growth of the healthcare third-party logistics market.

Major companies operating in the healthcare third-party logistics market are concentrating on developing innovative solutions, such as specialized cell and gene therapy logistics platforms, to ensure the secure, time-sensitive, and temperature-controlled delivery of advanced therapies. Specialized cell and gene therapy logistics platforms are sophisticated systems designed to manage the precise, time-critical, and temperature-regulated transportation and storage of delicate biological therapies used in personalized medicine. For instance, in October 2024, McKesson Corporation, a US-based healthcare company, launched Inspirogene, a dedicated business unit created to support the commercialization of cell and gene therapies through advanced third-party logistics and specialty distribution services. This solution integrates advanced supply chain management, temperature-controlled storage, and real-time tracking to maintain product integrity, ensure timely delivery, and enable efficient distribution of essential vaccines and therapies. Inspirogene provides a flexible platform tailored to the unique logistical requirements of cell and gene therapies, streamlining their delivery and supporting market entry with accuracy and reliability.

In April 2025, Morris & Dickson Inc., a US-based pharmaceutical wholesale distribution company, acquired Presa Solutions for an undisclosed amount. Through this acquisition, Morris & Dickson Inc. aims to deliver an integrated supply chain solution to pharmaceutical and biotechnology partners, expand its third-party logistics (3PL) capabilities, and offer an alternative to traditional large distributors. Presa Solutions Inc. is a US-based provider of healthcare third-party logistics (3PL) services.

Major companies operating in the healthcare third-party logistics market are McKesson Corporation, Cencora Inc, Cardinal Health Inc, Federal Express Corporation, AP Moller Maersk AS, Kuhne And Nagel International AG, Schenker AG, CEVA Logistics India Private Limited, GEODIS SA, Rhenus SE And Co KG, XPO Inc, Agility Logistics Private Limited, Allcargo Logistics Limited, Noatum Logistics India Private Limited, Barrett Distribution Centers Inc, UPS Supply Chain Solutions Inc, Buske Logistics Inc, DHL Supply Chain India Private Limited, Coldman Logistics Private Limited, AmerisourceBergen Logistics Services, DB Schenker Healthcare, Nippon Express Co Ltd.

North America was the largest region in the healthcare third-party logistics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare third-party logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the healthcare third-party logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the healthcare third-party logistics market by increasing costs of imported refrigeration units, monitoring sensors, packaging materials, and transport equipment required for cold chain and non-cold chain logistics. Pharmaceutical and medical device supply chains in North America and Europe are most affected due to reliance on imported logistics hardware, while Asia-Pacific faces higher operational costs for cross-border healthcare shipments. These tariffs are increasing logistics service pricing and compliance costs. However, they are also driving investments in regional logistics hubs, localized cold storage infrastructure, and domestic healthcare logistics capabilities.

The healthcare third-party logistics market research report is one of a series of new reports that provides healthcare third-party logistics market statistics, including healthcare third-party logistics industry global market size, regional shares, competitors with a healthcare third-party logistics market share, detailed healthcare third-party logistics market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare third-party logistics industry. This healthcare third-party logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Healthcare third-party logistics (3PL) refers to the outsourcing of logistics and supply chain management functions by healthcare companies to specialized external providers that manage critical operations such as transportation, warehousing, inventory management, and regulatory compliance. These providers also deliver value-added services, including cold chain handling, real-time tracking, serialization, and reverse logistics, to ensure the safe, efficient, and compliant delivery of temperature-sensitive pharmaceuticals, medical devices, and biologics across the supply chain.

The primary types of healthcare third-party logistics are cold chain logistics and non-cold chain logistics. Cold chain logistics involves the transportation and storage of temperature-sensitive products under controlled conditions to preserve their quality, safety, and efficacy throughout the supply chain. It uses multiple modes of transportation, including ground transport, air cargo, and ocean freight. It incorporates technologies such as automated storage and retrieval systems, warehouse management systems, transportation management systems, blockchain, the Internet of Things, artificial intelligence and machine learning, and robotics. Temperature control ranges include ambient, controlled, refrigerated, frozen, and cryogenic conditions. These services support a broad range of end users, including pharmaceutical and biopharmaceutical companies, hospitals and clinics, medical device manufacturers, research laboratories, healthcare providers, and others.

The healthcare third-party logistics market includes revenues earned by entities by providing services such as managing the storage, handling, and delivery of healthcare products, ensuring regulatory compliance, temperature control, secure distribution, and timely delivery to hospitals, clinics, pharmacies, and other healthcare institutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.